| PP100324000179 |
Kubota Pharmaceutical Holdings Co., Ltd. (since 2020), Acucela Inc. |
Retakubo, ACU-4429 |
emixustat hydrochloride |
Visual cyc.. |
Stargardt .. |
Phase III, Phase II completed, Phase II, Preclinical, Preclinical |
View Details
|
| PP081124002334 |
LadRx Corporation (since Sep 2022), CytRx Corporation |
INNO-206, DOXO-EMCH |
aldoxorubicin |
Intercalat.. |
2nd line s.. |
Phase III completed, Phase II, Phase II, Phase II |
View Details
|
| PP130805011737 |
KYORIN Pharmaceutical Co., Ltd. |
KRP-203 |
mocravimod |
A sphingos.. |
Acute myel.. |
Phase III, Phase II, Phase II, Phase II |
View Details
|
| PP131218011954 |
KUMHO HT INC.(since 2021), Dinona Inc. |
DNP001 |
|
Targeting .. |
Acute myel.. |
Phase I completed, Phase I completed |
View Details
|
| PP160104013721 |
Neuroderm, Ltd., a Mitsubishi Tanabe Pharma |
Onerji, ND0612H |
levodopa and carbidopa |
Levodopa c.. |
Severe Par.. |
Approved |
View Details
|
| PP160713014445 |
KUMHO HT INC.(since 2021), Dinona Inc. |
DNP002 |
|
Enhanced A.. |
Non-small-.. |
Phase I completed, Phase I completed, Phase I completed |
View Details
|
| PP160713014446 |
KUMHO HT INC.(since 2021), Dinona Inc. |
DNP004 |
|
Targeting .. |
Breast can.. |
Preclinical |
View Details
|
| PP170912016134 |
Kolon TissueGene, Inc. |
TG-D (DISC) |
an allogeneic (donor) cell. |
Cell repla.. |
Spinal dis.. |
Phase I |
View Details
|
| PP181224016919 |
Karyopharm Therapeutics |
KPT-8602 |
eltanexor |
To selecti.. |
Myelodyspl.. |
Phase II, Phase I completed |
View Details
|
| PP200228017971 |
Komipharm International Co., Ltd. |
Kominox, KML001 |
sodium metaarsenite, NaAsO2 |
Selectivel.. |
Prostate c.. |
Phase II, Phase II, Phase II, Phase II |
View Details
|